Zymergen has raised $300 million in financing. The investment total, announced yesterday, includes Series D funding led by Baillie Gifford, and joined by Baron Capital Group and one of the world’s largest sovereign wealth funds, as well as additional growth financing from Perceptive Advisors, the company said. A number of current investors are also returning, and Zymergen expects to raise additional capital in Q4 as part of a Series D round, according to a statement.
The new capital will be used to accelerate manufacturing of the company’s Hyaline film, which should be seen in commercial products as soon as next year, according to the company.
Zymergen is a science and material innovation company. They partner with nature to create previously unimaginable materials and are changing not only how things are made but what they are made of. Foldable electronics that actually fold, bacteria that eats plastic, an insect repellent as effective as it is natural, a solution to help farmers protect their crops to feed a growing global population. These are not pipe dreams, this is what they do every day.